Investor FAQs

Show All
When was Axonics Modulation Technologies founded?
Axonics Modulation Technologies was founded in March 2012 under the name “American Restorative Medicine, Inc.” In August 2013, the Company’s name was changed to Axonics Modulation Technologies, Inc. and operations commenced in late 2013.
Where is Axonics Modulation Technologies stock listed and what is the company’s ticker symbol?
Axonics Modulation Technologies is listed on the Nasdaq Global Select Market under the symbol “AXNX”
Where is Axonics Modulation Technologies located?
Axonics Modulation Technologies’ principal executive offices are located at 26 Technology Drive, Irvine, California 92618
When is the fiscal year-end for Axonics Modulation Technologies?
December 31st
Can I buy stock directly from Axonics Modulation Technologies?
No, please contact a licensed stock broker or use an online trading account
How can I obtain a copy of the Axonics Modulation Technologies Annual Report or any other investor materials?
Quarterly, annual and other investor reports & materials can be found in the IR section of the corporate website under ‘SEC Filings’. All SEC filings can also be accessed directly from the SEC at
Who are Axonics Modulation Technologies independent auditors?
Who is the transfer agent for Axonics Modulation Technologies and how does a registered shareholder contact the agent regarding account information?
  • ComputerShare Trust Company, N.A.
    250 Royall Street
    Canton, Massachusetts 02021
  • For help with change of address, transfer of shares, loss of share certificates, consolidation of multiple mailings to one shareholder & estate settlements please call (877) 373-6374 or email
Who is Axonics Modulation Technologies outside legal counsel?
K&L Gates LLP
Who can I contact if I want to learn more about Axonics Modulation Technologies?
Please send an email to
How can I sign up to receive Axonics Modulation Technologies press releases and other company information?
Please click on ‘Email Alerts’ under ‘Investor Resources’ in the IR section of the corporate website